Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.59 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.59 |
| ▸ | GAPDH | P04406 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10675596 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL31303623 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL12300775 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL8907239 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL2416572 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL11439694 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL11439697 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL10675600 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL12300774 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL7451666 | 0.98 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118146996-A | Brevibacterium and application thereof in improving cigar tobacco flavor quality | 中国烟草总公司海南省公司 | 2024-06-07 | — | — | CN | disclosed |
| US-8399399-B2 | compared with their structural isomer 2-methyl-4-dodecanal, are characterized by an odor threshold concentration which is up to 64 times lower | GIVAUDAN SA (CH) | 2013-03-19 | — | — | US | disclosed |
| EP-1743880-B1 | 3- and 4-methyl-dodecenal and their use in fragrance or flavour compositions | GIVAUDAN SA (CH) | 2011-09-28 | — | — | EP | disclosed |
| US-20080248177-A1 | 3- and 4-Methyl Dodecenal and their Use in Fragrance and Flavour Compositions | GIVAUDAN SA (CH) | 2008-10-09 | — | — | US | disclosed |
| EP-1743880-A1 | 3- and 4-methyl-dodecenal and their use in fragrance or flavour compositions | Givaudan S.A. (CH) | 2007-01-17 | — | — | EP | disclosed |
| WO-2006133591-A1 | 3-AND 4-METHYL-DODECENAL AND THEIR USE IN FRAGRANCE OF FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248177-A1 | 3- and 4-Methyl Dodecenal and their Use in Fragrance and Flavour Compositions | COXFA4, FADS2, DHCR24 | TRPA1 103/4885DDAH1 723/4885GAPDH 1051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.